Integrated Multi-Omics Landscape of Liver Metastases
Shuai Yang,Ling Qian,Zhixuan Li,Ye Li,Jian Bai,Bo Zheng,Kun Chen,Xinyao Qiu,Guoxiang Cai,Shan Wang,Haiyan Huang,Jianmin Wu,Yanjing Zhu,Qianwen Zhangyang,Lanyun Feng,Tong Wu,Rui Wu,Airong Yang,Kaiting Wang,Ruiru Wang,Yani Zhang,Yan Zhao,Wenwen Wang,Jinxia Bao,Siyun Shen,Ji Hu,Xuan Wu,Tao Zhou,Zhiqiang Meng,Weiwei Liu,Hongyang Wang,Peng Wang,Lei Chen
DOI: https://doi.org/10.1053/j.gastro.2022.11.029
IF: 29.4
2023-03-01
Gastroenterology
Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND & AIMS">Lack of thorough knowledge about the complicated immune microenvironment (IM) within a variety of liver metastases (LMs) leads to inappropriate treatment and unsatisfactory prognosis. We aimed to characterize IM subtypes and investigate potential mechanisms in LMs.</AbstractText>METHODS: <AbstractText Label="METHODS">Mass cytometry was applied to characterize immune landscape of a primary liver cancers and liver metastases cohort. Transcriptomic and whole-exome sequencing were used to explore potential mechanisms across distinct IM subtypes. Single-cell transcriptomic sequencing, multiplex fluorescent immunohistochemistry, cell culture, mouse model, Western blot, quantitative polymerase chain reaction, and immunohistochemistry were used for validation.</AbstractText>RESULTS: <AbstractText Label="RESULTS">Five IM subtypes were revealed in 100 LMs and 50 primary liver cancers. Patients featured terminally exhausted (IM1) or rare T-cell-inflamed (IM2 and IM3) immune characteristics showed worse outcome. Increased intratumor heterogeneity, enriched somatic TP53, KRAS, APC, and PIK3CA mutations and hyperactivated hypoxia signaling accounted for the formation of vicious subtypes. SLC2A1 promoted immune suppression and desert via increasing proportion of Spp1<sup>+</sup> macrophages and their inhibitory interactions with T cells in liver metastatic lesions. Furthermore, SLC2A1 promoted immune escape and LM through inducing regulatory T cells, including regulatory T cells and LAG3<sup>+</sup>CD4<sup>+</sup> T cells in primary colorectal cancer.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">The study provided integrated multi-omics landscape of LM, uncovering potential mechanisms for vicious IM subtypes and confirming the roles of SLC2A1 in regulating tumor microenvironment remodeling in both primary tumor and LM lesions.</AbstractText>
gastroenterology & hepatology